Yahoo Web Search

Search results

    • Why Is OptiNose (OPTN) Stock Up 12% Today?

      Why Is OptiNose (OPTN) Stock Up 12% Today?

      InvestorPlace· 7 days ago

      Food and Drug Administration (FDA). The expansion news includes the FDA signing off on XHANCE being used as a treatment for adult patients with chronic...